Malaria vaccine

BIOLOGICAL3 trials

Sponsors

University of Oxford, PATH, Kenya Medical Research Institute

Conditions

MalariaMalaria VaccinePlasmodium Vivax Infection

Phase 2

A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )

Not yet recruitingNCT05380388

University of OxfordMalaria Vaccine, Plasmodium Vivax Infection

Start: 2027-01-01End: 2027-12-30Target: 36Updated: 2026-03-24

Infant Malaria Vaccine Schedule Optimization

RecruitingPACTR202411825510335

Start: 2025-03-03Target: 1200Updated: 2026-01-27

Unknown Phase

Optimising malaria control strategies in western Kenya

Active, not recruitingPACTR202512777984045

Kenya Medical Research InstituteMalaria

Start: 2026-03-02Target: 7200Updated: 2026-01-27